Intrinsic Value of S&P & Nasdaq Contact Us

Solventum Corporation SOLV NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
73/100
6/7 Pass
SharesGrow Intrinsic Value
$6.98
-89.9%
Analyst Price Target
$100.50
+45.6%

Solventum Corporation (SOLV) reported total assets of $14.29B and total liabilities of $9.25B for quarter ending 2025-12-31, resulting in total equity of $5.05B.

The company held $878M in cash and short-term investments. Total debt stood at $5.04B, with net debt of $4.16B. The Debt-to-Equity (D/E) ratio was 1 (moderate).

Current ratio is 1.23, suggesting adequate short-term liquidity. Interest coverage is 32.9x (strong).

Criteria supported by this page:

  • HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (71/100) — Total assets $14.29B and equity $5.05B support the company's competitive scale
  • VALUE (76/100) — Debt-to-Equity 1 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 73/100 with 6/7 criteria passed.

SharesGrow 7-Criteria Score
73/100
SG Score
View full scorecard →
VALUE
76/100
Price-to-Earnings & upside
→ Valuation
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
71/100
Proven by this page
GROWTH
73/100
→ Income
INCOME
70/100
→ Income
Solventum Corporation Balance Sheet History
Metric Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Total Assets $14.29B$13.97B$15.07B$14.53B
Total Liabilities $9.25B$8.99B$11.43B$11.27B
Total Debt $5.04B$5.14B$7.82B$7.91B
Cash & Investments $878M$1.64B$492M$534M
Total Stockholders Equity $5.05B$4.99B$3.65B$3.26B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message